Arcadia Biosciences (RKDA) Gross Margin (2014 - 2025)

Arcadia Biosciences has reported Gross Margin for 12 years, with the latest figure at 21.31% in Q4 2025.

• For the quarter ending Q4 2025, Gross Margin fell 1068.0% year-over-year to 21.31%; the trailing twelve-month figure through Dec 2025 stood at 36.21% (down 507.0% YoY), and the FY2025 full-year result was 36.23%, down 504.0% from the prior year.
• Gross Margin for Q4 2025 stood at 21.31%, down from 32.1% in the prior quarter.
• The five-year high for Gross Margin was 115.49% in Q4 2022, with the low at 7.39% in Q1 2022.
• Historically, Gross Margin has averaged 38.35% across 5 years, with a median of 34.92% in 2023.
• Annual changes were most pronounced in 2021 — Gross Margin jumped 53006 bps — and 2022, when it sank 8916 bps.
• Arcadia Biosciences' Gross Margin stood at 12.7% in 2021, then soared by 809 bps to 115.49% in 2022, then slumped by 33 bps to 77.09% in 2023, then tumbled by 59 bps to 31.99% in 2024, then plunged by 33 bps to 21.31% in 2025.
• The last three Gross Margin figures came in at 21.31% (Q4 2025), 32.1% (Q3 2025), and 43.37% (Q2 2025), per Business Quant data.